Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2012
06/05/2012CA1341630C Transformation vectors allowing expression of foreign polypeptide endotoxins in plants
05/2012
05/31/2012WO2012071592A2 A humanized transgenic animal
05/31/2012WO2012071549A2 Inducible expression system transcription modulators comprising a distributed protein transduction domain and methods for using the same
05/31/2012WO2012071547A2 Metabolic switch
05/31/2012WO2012071527A2 Protein delivery from stem cell microcarriers
05/31/2012WO2012071513A2 Expanding hematopoietic stem cells
05/31/2012WO2012071393A2 Method for producing pluripotent stem cells
05/31/2012WO2012071108A1 Somatic cell-derived pluripotent cells and methods of use therefor
05/31/2012WO2012071096A2 Arid1a and ppp2r1a mutations in cancer
05/31/2012WO2012070758A2 Fusion protein for tooth and bone regeneration
05/31/2012WO2012070639A1 Neuron-specific retrograde transport vector
05/31/2012WO2012070622A1 Method and material for separating leukocytes or mononuclear cells
05/31/2012WO2012070008A2 Recombinant proteins with a selective inactivation activity on target proteins
05/31/2012WO2012070001A1 An explant culture technique for isolation of mesenchymal stem cells from adipose tissue
05/31/2012WO2012069841A1 Bioreactor
05/31/2012WO2012068710A1 Methods for extracting mesenchymal stem cell from slight amount human adipose tissue and mass cultivation thereof
05/31/2012WO2012037505A3 Polymeric support with nanofeatures for cell culture
05/31/2012WO2012036512A3 Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells
05/31/2012WO2012032521A8 Novel methods and culture media for culturing pluripotent stem cells
05/31/2012WO2012030540A3 Differentiation of pluripotent stem cells
05/31/2012WO2012030539A3 Differentiation of human embryonic stem cells
05/31/2012WO2012018955A3 Cellular compositions and methods for their preparation and use
05/31/2012WO2012008764A3 Composition for inducing multiple nuclear division of cells
05/31/2012WO2011157447A3 Modified parvovirus having enhanced anti-tumour efficacy
05/31/2012US20120137390 Materials and methods for regeneration and transformation of trees
05/31/2012US20120137388 Cucumber Vein Yellowing Virus (CVYV) Resistant Cucumber Plants (Cucumis Sativus L.)
05/31/2012US20120137387 Methods for genetic control of insect infestation in plants and compositions thereof
05/31/2012US20120137386 Plants Having Modulated Carbon Partitioning and a Method for Making the Same
05/31/2012US20120137385 Transcription factors
05/31/2012US20120137383 Lettuce variety intred
05/31/2012US20120137382 Stress tolerance in plants
05/31/2012US20120137381 Tomato hybrid ps 01565172
05/31/2012US20120137380 Squash hybrid px 13056719
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136141 Integrin Heterodimer And A Subunit Thereof
05/31/2012US20120136140 Anti-cadherin antibody
05/31/2012US20120136073 Amine-Containing Transfection Reagents and methods for making and using same
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136042 Carbohydrate conjugates as delivery agents for oligonucleotides
05/31/2012US20120136033 Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof
05/31/2012US20120136029 Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120135990 Iap inhibitors
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135938 Polypeptides that Bind TRAIL-R1 and TRAIL-R2
05/31/2012US20120135931 Method of modifying serine protease inhibitors
05/31/2012US20120135926 Peptides for inhibiting igf-1
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135878 Generation of Neural Stem Cells from Human Trophoblast Stem Cells
05/31/2012US20120135525 Reprogramming t cells and hematopoietic cells
05/31/2012US20120135523 Preparation and uses of polyarylates
05/31/2012US20120135522 Methods of modulating cell regulation by inhibiting p53
05/31/2012US20120135521 Antigene locks and therapeutic uses thereof
05/31/2012US20120135520 Unshrunken tissue equivalent, skin equivalent comprising such an unshrunken tissue equivalent, and methods for producing such an unshrunken tissue equivalent and such a skin equivalent
05/31/2012US20120135519 INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM
05/31/2012US20120135518 Defined surfaces of self-assembled monolayers and stem cells
05/31/2012US20120135517 Synthetic genes and genetic constructs
05/31/2012US20120135516 Artificial antibody polypeptides
05/31/2012US20120135503 Minicell based delivery of biologically active compounds
05/31/2012US20120135501 Recombinant poxvirus expressing homologous genes inserted
05/31/2012US20120135495 Neurotoxins with enhanced target specificity
05/31/2012US20120135486 Methods and Compositions for the Extracellular Transport of Biosynthetic Hydrocarbons and Other Molecules
05/31/2012US20120135469 Novel glycosyltransferase, novel glycosyltransferase gene, and novel sugar donor compound
05/31/2012US20120135467 Hmo synthesis
05/31/2012US20120135464 Stirrer system
05/31/2012US20120135460 Recombinant porcine chymotrypsin
05/31/2012US20120135452 Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof
05/31/2012US20120135448 Methods and devices for the fabrication of 3d polymeric fibers
05/31/2012US20120135447 Nucleic acids encoding t2r, a novel family of taste receptors
05/31/2012US20120135445 Cell transport system
05/31/2012US20120135416 Compositions And Methods For Treating And Diagnosing Pancreatic Cancer
05/31/2012US20120135408 Unc-45a splice variants based cancer diagnostics and therapeutics
05/31/2012US20120135391 Method of Blood Pooling and Storage
05/31/2012US20120135064 Conjugated nanodelivery vehicles
05/31/2012US20120135054 Poly (Ester Ether Amide)s and Uses Thereof
05/31/2012US20120135051 Generation of vascularized human heart tissue and uses thereof
05/31/2012US20120135049 Decellularized tissue engineered constructs and tissues
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135038 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135020 Ttk peptides and vaccines including the same
05/31/2012US20120135015 Induction of Pancreatic Stem Cells by Transient Overexpression of Reprogramming Factors and PDX1 Selection
05/31/2012US20120135013 CD45 and Methods and Compounds Related Thereto
05/31/2012US20120135010 High affinity human antibodies to human il-4 receptor
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES
05/31/2012US20120135004 Antibodies to matrix metalloproteinase 9
05/31/2012US20120135003 Anti-ilt7 antibody
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134993 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
05/31/2012US20120134992 Mesothelin antibody protein fusions and methods of use
05/31/2012US20120134984 Molecules with extended half-lives and uses thereof
05/31/2012US20120134975 Biological targeting compositions and methods of using the same
05/31/2012US20120134972 Novel Polypeptides Having Endolysin Activity And Uses Thereof
05/31/2012US20120134971 Engineered biological pacemakers
05/31/2012US20120134970 Viral Vectors Encoding Multiple Highly Homologus Non-Viral Polypeptides And The Use Of Same
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134968 Composition for manufacturing a scaffold for tissue engineering, and a method of making it
05/31/2012US20120134967 Scaffolds For Cell Transplantation
05/31/2012US20120134966 Embryonic stem cell specific micrornas promote induced pluripotency
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1827